H. Lundbeck A/S Newsletter
-
Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
06 Dec 2025 21:42 GMT
… #47; — H. Lundbeck A/S (Lundbeck) today announced results from … presentations at AES 2025, Lundbeck demonstrates the breadth of its … 01
About H. Lundbeck A/S
Lundbeck is a biopharmaceutical … #47;news-releases/lundbeck-announces-positive-phase-2-long …
-
Lundbeck To Present Comprehensive New Bexicaserin Dataset In Patients With Rare Childhood-Onset Epilepsies, At American Epilepsy Society (AES) Annual Meeting
02 Dec 2025 10:09 GMT
… Eight presentations at AES highlight Lundbeck's dedication to … Research & Development at Lundbeck. "The data for …
During the AES congress, Lundbeck will also showcase two-year … have not been established.
Lundbeck's scientific presentations …
-
Lundbeck Ends Bidding War for Avadel, After Alkermes’ Up-to-$2.37B Offer
02 Dec 2025 05:16 GMT
… value creation,” Lundbeck said in a statement. “Lundbeck’s disciplined … psychiatry. Within neurology, Lundbeck’s sub-focus areas … sleep-wake disorders
“Lundbeck continues to assess opportunities … the company further stated.
Lundbeck finished the third quarter …
-
Lundbeck bows out of bidding war for Avadel
27 Nov 2025 20:57 GMT
… ."
It added: "Lundbeck's disciplined approach requires … review, Avadel concluded that Lundbeck's offer was … achieved."
"While Lundbeck is discontinuing this specific process … fully intact," said Lundbeck, which added that it …
-
Lundbeck backs out of bidding war for sleep disorder biotech Avadel
26 Nov 2025 23:05 GMT
-
Alkermes offers more for Avadel after Lundbeck bid
20 Nov 2025 00:58 GMT
… after a rival bid from Lundbeck was deemed superior.
Dublin … Avadel announced their deal, Lundbeck made an unsolicited offer … After carefully assessing both the Lundbeck proposal and Alkermes… has determined that the Lundbeck proposal no longer constitutes …
-
After Lundbeck's surprise bid, Alkermes sweetens deal to acquire Avadel
19 Nov 2025 22:09 GMT
… s first quarter. Meanwhile, Lundbeck, which cut in on Alkermes … success. For its part, Lundbeck put up a bid … pitch, Avadel acknowledged that Lundbeck’s unsolicited bid constituted a … original transaction agreement.
While Lundbeck’s offer had a slightly …
-
Alkermes prevails over Lundbeck in Avadel bidding war
19 Nov 2025 19:07 GMT
… disorder drugmaker Avadel, following Lundbeck’s last-minute bid to … the offer, deeming the Lundbeck offer no longer superior
Discover … then intercepted by Danish pharma Lundbeck via an unsolicited bid, … war between Alkermes and Lundbeck looks familiar to the …
-
UPDATE: Avadel Accepts Alkermes' Revised $2.37B Counteroffer, Besting Lundbeck
19 Nov 2025 14:20 GMT
… carefully assessing both the Lundbeck Proposal and Alkermes’ Increased … has determined that the Lundbeck Proposal no longer … Alkermes’ original acquisition proposal.
Lundbeck has priced Avadel at … But three weeks later, Lundbeck entered the picture, narrowly …
-
Alkermes raises offer for Avadel after Lundbeck bid
19 Nov 2025 11:28 GMT
… bid from Denmark's Lundbeck and valuing the sleep disorder …
About
© 1995-2025